sorafenib has been researched along with Arthritis, Rheumatoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Huang, T; Huang, X; Liu, B; Wang, J; Wang, Z; Yu, Q | 1 |
| de Waal, R; Hulsbergen-van de Kaa, C; Kats-Ugurlu, G; Leenders, W; Maass, C; Mulders, P; Oosterwijk, E; van Herpen, C | 1 |
2 other study(ies) available for sorafenib and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Sorafenib suppresses proliferation rate of fibroblast-like synoviocytes through the arrest of cell cycle in experimental adjuvant arthritis.
Topics: Animals; Antirheumatic Agents; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Culture Techniques; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Down-Regulation; Fibroblasts; G1 Phase Cell Cycle Checkpoints; Hyperplasia; Mice; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Sorafenib; Synovial Membrane; Synoviocytes | 2021 |
Better effect of sorafenib on the rhabdoid component of a clear cell renal cell carcinoma owing to its higher level of vascular endothelial growth factor-A production.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Benzenesulfonates; Carcinoma, Renal Cell; Clinical Trials as Topic; Depression; Female; Humans; Hypertension; Kidney Neoplasms; Middle Aged; Neoadjuvant Therapy; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Vascular Endothelial Growth Factor A | 2011 |